Immunization of HLA-A1 and/or HLA-A2 positive patients
Clinical protocolHLA-A1 and/or HLA-A2 positive patients are immunized with autologous DC loaded with KLH, as immunological tracer, and an allogeneic peptidome (i.e. natural tumour peptides, NTPs), obtained from melanoma cell line SK-Mel24.
Protocol Steps:

created over 16 years ago
(2 March 2009)
last modified over 14 years ago
(28 September 2011)
 [ RDF ]
 [ RelFinder
]